Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Interaction between thymic hormones and other immunomodulatory agents.

A Mastino1, C Favalli, S Grelli

  • 1Dipartimento di Medicina Sperimentale e Scienze Biochimiche, Università degli Studi Tor Vergata, Rome, Italy.

Annali Dell'Istituto Superiore Di Sanita
|January 1, 1991
PubMed
Summary

Combination therapy with thymosin alpha 1 (TA1) and interferon (IFN) restored natural killer (NK) cell activity in mice with B-16 melanoma. This immunotherapy approach also prolonged survival, suggesting potential for cancer treatment.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

High body mass index and night shift work are associated with COVID-19 in health care workers.

Journal of endocrinological investigation·2020
Same author

Measles immunity in an Italian teaching hospital.

Occupational medicine (Oxford, England)·2018
Same author

Comparison of coronal leakage of different root canal filling techniques: an ex vivo study.

Journal of biological regulators and homeostatic agents·2018
Same author

Mechanism of Action of Thymosinα1: Does It Interact with Membrane by Recognition of Exposed Phosphatidylserine on Cell Surface? A Structural Approach.

Vitamins and hormones·2016
Same author

Serum thymosin α 1 levels in patients with chronic inflammatory autoimmune diseases.

Clinical and experimental immunology·2016
Same author

miR-34a regulates cell proliferation, morphology and function of newborn neurons resulting in improved behavioural outcomes.

Cell death & disease·2015

Area of Science:

  • Immunology
  • Cancer Research
  • Pharmacology

Background:

  • Natural killer (NK) cell activity is crucial for anti-tumor immunity.
  • Tumor growth can lead to suppression of NK cell activity.
  • Interferon (IFN) can enhance NK activity, but its effectiveness is diminished in later stages of tumor progression.

Purpose of the Study:

  • To investigate the combined effects of thymosin alpha 1 (TA1) and murine alpha/beta interferon (IFN) on NK activity and tumor growth.
  • To evaluate the therapeutic potential of TA1 and IFN combination therapy in a B-16 melanoma mouse model.

Main Methods:

  • Mice bearing B-16 melanoma were treated with TA1 and IFN, alone or in combination.
  • NK cell activity was measured at different time points post-tumor inoculation.

Related Experiment Videos

  • Tumor growth and survival rates were monitored.

    • Main Results:

    • Single IFN treatment enhanced NK activity early after tumor inoculation but not when NK cells were suppressed.
    • Combination therapy with TA1 and IFN restored normal NK cell activity, even when NK responses were suppressed.
    • Combination therapy did not affect primary tumor growth but significantly prolonged survival in tumor-bearing mice.

    Conclusions:

    • Combination therapy with TA1 and IFN can restore NK cell activity in the presence of tumor-induced suppression.
    • This combined immunotherapy approach shows promise for improving survival in cancer models.
    • TA1 and IFN combination therapy warrants further investigation as a potential cancer immunotherapy strategy.